Birdshot chorioretinopathy: What’s new

An update on diagnosis and treatment, including the role of multimodal imaging and combination therapy.

Masquerade syndromes in uveitis

A review of neoplastic and nonneoplastic masqueraders that can confound and complicate diagnosis.

Managing UGH syndrome

Uveitis-glaucoma-hyphema syndrome, or Ellingson syndrome, requires surgery targeting the intraocular lens to resolve the cause of chafing.

Treating uveitic macular edema

A review of local and systemic treatments for UME and insights on when to use them.

Uveitis risk of ICPIs for cancer

Immune checkpoint inhibitors are becoming more widely available, but they’ve been linked to uveitis in some patients.

Using anti-VEGF agents in uveitis

A review of the available evidence and anecdotal reports supporting their use.

Retinal implant platforms moving from uveitis to AMD

Treatments show potential for various posterior-segment diseases based on their success treating noninfectious uveitis.

Taking treatment beyond adalimumab

An update on biologic alternatives for ocular inflammatory disease when the approved agent just won’t cut it.

How COVID-19 has altered uveitis management

The pandemic has potentially changed the risk-benefit balance between local therapy and systemic immunosuppression.

Noninfectious uveitis in pregnancy

Knowing the options available for safely treating pregnant patients will empower retina specialists to confidently care for them.